Insulin resistance (IR), a central feature of obesity-related metabolic dysregulation, manifests as reduced insulin responsiveness in adipose, hepatic, and muscle tissues, ultimately leading to β-cell failure and T2DM onset. This evidence concerns the gene INS and obesity disorder.